Directory

>

Art Taveras

avatar

Art Taveras

Chief Scientific Officer | X4 Pharmaceuticals

United States

View contact details (it's free)

Art Taveras

Summary

Art Taveras is a distinguished Chief Scientific Officer at X4 Pharmaceuticals, specializing in the discovery and development of small molecule drugs targeting neurodegeneration, cancer, and metabolic diseases. With a robust background in organic chemistry and extensive leadership experience, he has successfully led over 50 R&D programs, contributing to the development of multiple FDA-approved drugs. His innovative work has resulted in over 130 patents and more than 90 publications, showcasing his significant impact on the pharmaceutical industry. Art's entrepreneurial spirit is evident from founding Transform Therapeutics, where he pioneered new therapeutic classes for cancer treatment. He is passionate about advancing drug discovery through technology transfer and collaboration with global biotech firms. Fluent in the language of science, Art is not only a leader but also a mentor to emerging scientists in the field. His commitment to research excellence continues to drive breakthroughs in biopharmaceuticals.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Art Taveras

Work Experience

company logo

Chief Scientific Officer at

X4 Pharmaceuticals

November 2020 - Present

💼

Founder; Served as Chief Scientific Officer, Head of Drug Discovery at

Transform Therapeutics, LLC

May 2015 - November 2020

company logo

Chief Scientific Officer at

CRISPR Therapeutics

August 2018 - July 2020

company logo

President & Chief Scientific Officer at

ChemPartner

January 2013 - December 2014

company logo

Vice President Small Molecules Drug Discovery & CMC Development at

Biogen

January 2007 - January 2013

💼

Vice President Drug Discovery & CMC Development at

Alantos Pharmaceuticals, Inc.

May 2004 - November 2007

💼

Drug Discovery, Sr Scientist to Director D2 Level at

Schering-Plough Research Institute

January 1990 - May 2004

Logos provided by Logo.dev

Art Taveras

Education

Boston College - Woods College of Advancing Studies

January 2017 - January 2018

Rensselaer Polytechnic Institute, Doctor Of Philosophy (Ph.D.; Dissertation 1991); M.S. (Magna Cum Laude); B.S. (1986; Cum Laude)

January 1982 - January 1990

Frequently Asked Questions about Art Taveras

What is Art Taveras email address?

Art Taveras's primary email address is ***********@x4pharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Art Taveras work for?

Art Taveras is a Chief Scientific Officer at X4 Pharmaceuticals, a company specializing in Commercial physical research.

Where Art Taveras graduated from?

Art Taveras holds a degree in Advanced Studies from Boston College - Woods College of Advancing Studies.

How can I directly contact Art Taveras?

To contact Art Taveras directly, you can use the email address ***********@x4pharma.com. Complete contact information is available upon registration with Muraena.

Who is Art Taveras?

Art Taveras is a distinguished Chief Scientific Officer at X4 Pharmaceuticals, specializing in the discovery and development of small molecule drugs targeting neurodegeneration, cancer, and metabolic diseases. With a robust background in organic chemistry and extensive leadership experience, he has successfully led over 50 R&D programs, contributing to the development of multiple FDA-approved drugs. His innovative work has resulted in over 130 patents and more than 90 publications, showcasing his significant impact on the pharmaceutical industry. Art's entrepreneurial spirit is evident from founding Transform Therapeutics, where he pioneered new therapeutic classes for cancer treatment. He is passionate about advancing drug discovery through technology transfer and collaboration with global biotech firms. Fluent in the language of science, Art is not only a leader but also a mentor to emerging scientists in the field. His commitment to research excellence continues to drive breakthroughs in biopharmaceuticals.

Art`s contact details

mail

***********@x4pharma.com

Colleagues

avatar
Paula Ragan

Founder, President and CEO

avatar
Francoise De Craecker

Independent Board Member(Non Executive Director)

avatar
Thienhuu Nguyen

Vice President, Commercial Operations

avatar
Barbara Grell

Managing Director, Vienna Research Site

avatar
Deb Steiner

Vice President Clinical Development

avatar
Brian Bowersox

Vice President Finance, Corporate Controller

avatar
Gail Hartigan

Vice President, US Sales

avatar
Jill Elliott

Vice President, Head of Marketing

avatar
Mary Dibiase

Chief Operating Officer

avatar
Marie Green

Program Executive and Vice President Program Management

View Contact details (it's free)
Request Profile Removal